Received Mar 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | NR5DX | — |
Boostrix + expired dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 10-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number NR5DX, expiry date 02-FEB-2026) for prophylaxis. On 09-MAR-2026, the patient received Boostrix. On 09-MAR-2026, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: Boostrix + expired dose). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 09-MAR-2026 This case was linked with US2026032939, reported by same reporter for different patient; Sender's Comments: US-GSK-US2026032939:Same reporter/Different patient